Arcutis Biotherapeutics, Inc.
ARQT
$22.91
$0.673.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.06% | -42.20% | -47.35% | -50.95% | -16.15% |
| Total Receivables | 100.13% | 91.48% | 145.76% | 129.89% | 183.12% |
| Inventory | 55.82% | 59.96% | 17.61% | 25.42% | 10.60% |
| Prepaid Expenses | -5.64% | 16.66% | -25.93% | 21.51% | 21.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 22.63% | 0.19% | 226.01% | 1,122.20% | -16.23% |
| Total Current Assets | 22.46% | -17.58% | -23.43% | -30.85% | 1.63% |
|
|
|||||
| Total Current Assets | 22.46% | -17.58% | -23.43% | -30.85% | 1.63% |
| Net Property, Plant & Equipment | 84.03% | 78.13% | -11.05% | -8.12% | -23.23% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 56.26% | 57.02% | 162.86% | 164.00% | 47.24% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 138.09% | 0.00% | 0.17% | 0.00% | 0.00% |
| Total Assets | 24.10% | -15.18% | -20.76% | -28.09% | 2.20% |
|
|
|||||
| Total Accounts Payable | -11.90% | -70.01% | 89.88% | 89.14% | 18.58% |
| Total Accrued Expenses | 74.14% | 76.12% | 106.08% | 95.80% | 96.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -99.00% | 28.70% | 11.38% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 60.27% | -42.14% | 102.40% | 92.63% | 73.59% |
|
|
|||||
| Total Current Liabilities | 60.27% | -42.14% | 102.40% | 92.63% | 73.59% |
| Long-Term Debt | 0.71% | 2.29% | -47.48% | -46.93% | -46.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 105.54% | 90.33% | -29.01% | -26.44% | -24.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -24.39% | -14.29% | 85.57% | 17.65% | -32.86% |
| Total Liabilities | 27.25% | -24.16% | -17.37% | -20.56% | -24.28% |
|
|
|||||
| Common Stock & APIC | 3.76% | 3.66% | 3.63% | 3.82% | 19.52% |
| Retained Earnings | -1.44% | -3.99% | -8.72% | -12.75% | -14.26% |
| Treasury Stock & Other | -528.57% | -111.63% | 88.10% | -5.26% | -275.00% |
| Total Common Equity | 20.27% | 0.91% | -25.45% | -36.58% | 77.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.27% | 0.91% | -25.45% | -36.58% | 77.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.27% | 0.91% | -25.45% | -36.58% | 77.68% |
|
|
|||||